2024
Parent-Clinician Communication and Prolonged Grief in Parents Whose Child Died From Cancer
Ouyang N, Baker J, Ananth P, Knobf M, Snaman J, Feder S. Parent-Clinician Communication and Prolonged Grief in Parents Whose Child Died From Cancer. Journal Of Pain And Symptom Management 2024, 68: 516-524.e1. PMID: 39142495, DOI: 10.1016/j.jpainsymman.2024.08.003.Peer-Reviewed Original ResearchEnd-of-lifeParent-clinician communicationProlonged grief symptomsGrief symptomsChild's end-of-lifeCross-sectional survey of parents of childrenEnd-of-life careHigh-quality end-of-lifeProlonged griefSum scoreSurvey of parents of childrenCross-sectional surveyParents of childrenAdequate prognostic informationBereaved parentsPrognostic informationChild deathsParents' experiencesMultiple linear regressionPG-13Analyzed dataLinear regressionAssociationGriefChildren
2020
Parent Perceptions of Team-Delivered Care for Children With Advanced Cancer: A Report From the PediQUEST Study
Feraco AM, Ananth P, Dussel V, Al-Sayegh H, Ma C, Rosenberg AR, Feudtner C, Wolfe J. Parent Perceptions of Team-Delivered Care for Children With Advanced Cancer: A Report From the PediQUEST Study. Journal Of Pain And Symptom Management 2020, 60: 811-817. PMID: 32450115, PMCID: PMC7508972, DOI: 10.1016/j.jpainsymman.2020.05.019.Peer-Reviewed Original ResearchConceptsAdvanced cancerCare teamIndividual cliniciansExact testCare qualityRatings of careFisher's exact testHealth care teamSymptom management trialsParents' perceptionsChildhood cancer careCross-sectional surveyOne-third reportInterprofessional health care teamsCare of childrenClinician typePediQUEST studyPrimary outcomeParents of childrenCancer careAssociated FactorsRefractory cancerChild's oncologistExcellent careCancer
2018
Provider Perspectives on Use of Medical Marijuana in Children With Cancer
Ananth P, Ma C, Al-Sayegh H, Kroon L, Klein V, Wharton C, Hallez E, Braun I, Michelson K, Rosenberg AR, London W, Wolfe J. Provider Perspectives on Use of Medical Marijuana in Children With Cancer. Pediatrics 2018, 141: e20170559. PMID: 29233937, PMCID: PMC5744275, DOI: 10.1542/peds.2017-0559.Peer-Reviewed Original ResearchConceptsPediatric oncology providersMedical marijuanaOncology providersMM useProvider perspectivesCancer-directed therapyPercent of providersCross-sectional surveyLogistic regression modelsWilcoxon rank testSupportive careMedian ageOral formulationMM practiceSerious illnessMost providersGroup comparisonsCancerPrevious monthRank testState-specific regulationsChildrenRegression modelsImportant barriersGreatest barrier